Literature DB >> 9070134

Serum screening for Down's syndrome: how much do health professionals know?

M Sadler1.   

Abstract

OBJECTIVE: To assess knowledge about serum screening for Down's syndrome in health professionals involved in antenatal care.
DESIGN: Postal questionnaire survey of knowledge of performance and interpretation of serum screening.
SETTING: Portsmouth and South East Hampshire health district. POPULATION: All health professionals likely to be involved in antenatal care.
METHODS: Questionnaires were sent to all general practitioners (n = 288), hospital midwives (n = 129), community midwives (n = 71), and obstetricians (n = 29) working in the district. MAIN OUTCOME MEASURES: Total number of correct responses given to eight factual questions and percentage of correct responses to each individual question.
RESULTS: Responses were received from 434 health professionals (84%). Fifty-nine percent of health professionals correctly answered only a half or less of the factual questions on serum screening. Questions relating to the sensitivity, specificity, and positive predictive value were particularly poorly answered. Obstetricians scored most highly. General practitioners scored significantly less than the other groups.
CONCLUSIONS: Women need accurate information to give informed consent to serum screening. Most health professionals likely to be involved in antenatal care in this district do not fully understand the test and are thus unlikely to provide such information. Changes in the provision of maternity services following Changing Childbirth may increase the input of midwives and general practitioners. Training of professionals about serum screening should be reviewed.

Entities:  

Mesh:

Year:  1997        PMID: 9070134     DOI: 10.1111/j.1471-0528.1997.tb11040.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  4 in total

1.  Information and decision support needs of parents considering amniocentesis: interviews with pregnant women and health professionals.

Authors:  Marie-Anne Durand; Mareike Stiel; Jacky Boivin; Glyn Elwyn
Journal:  Health Expect       Date:  2010-06       Impact factor: 3.377

2.  Screening for nuchal translucency. Measurements give parents useful information.

Authors:  S Carroll
Journal:  BMJ       Date:  1998-09-12

3.  Participation in maternal serum screening for Down syndrome, neural tube defects, and trisomy 18 following screen-positive results in a previous pregnancy.

Authors:  D N Rausch; G M Lambert-Messerlian; J A Canick
Journal:  West J Med       Date:  2000-09

4.  Six year survey of screening for Down's syndrome by maternal age and mid-trimester ultrasound scans.

Authors:  D T Howe; R Gornall; D Wellesley; T Boyle; J Barber
Journal:  BMJ       Date:  2000-03-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.